274 related articles for article (PubMed ID: 25030607)
1. Deciphering next-generation pharmacogenomics: an information technology perspective.
Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
[TBL] [Abstract][Full Text] [Related]
2. Towards population-specific pharmacogenomics in the era of next-generation sequencing.
Ji X; Ning B; Liu J; Roberts R; Lesko L; Tong W; Liu Z; Shi T
Drug Discov Today; 2021 Aug; 26(8):1776-1783. PubMed ID: 33892143
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
Ji Y; Si Y; McMillin GA; Lyon E
Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
[TBL] [Abstract][Full Text] [Related]
4. Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: A review.
Vaidhya A; Ghildiyal K; Rajawat D; Nayak SS; Parida S; Panigrahi M
Anim Genet; 2024 Feb; 55(1):3-19. PubMed ID: 37990577
[TBL] [Abstract][Full Text] [Related]
5. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine.
Salleh MZ; Teh LK; Lee LS; Ismet RI; Patowary A; Joshi K; Pasha A; Ahmed AZ; Janor RM; Hamzah AS; Adam A; Yusoff K; Hoh BP; Hatta FH; Ismail MI; Scaria V; Sivasubbu S
PLoS One; 2013; 8(8):e71554. PubMed ID: 24009664
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
[TBL] [Abstract][Full Text] [Related]
7. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
[TBL] [Abstract][Full Text] [Related]
8. Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug Therapy.
Zhou Y; Lauschke VM
Handb Exp Pharmacol; 2023; 280():237-260. PubMed ID: 35792943
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics: Precision Medicine and Drug Response.
Weinshilboum RM; Wang L
Mayo Clin Proc; 2017 Nov; 92(11):1711-1722. PubMed ID: 29101939
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
Zhou Y; Lauschke VM
Expert Rev Clin Pharmacol; 2024 Mar; 17(3):213-223. PubMed ID: 38247431
[TBL] [Abstract][Full Text] [Related]
12. Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives.
Brlek P; Bulić L; Bračić M; Projić P; Škaro V; Shah N; Shah P; Primorac D
Cells; 2024 Mar; 13(6):. PubMed ID: 38534348
[TBL] [Abstract][Full Text] [Related]
13. Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine.
Mitropoulos K; Innocenti F; van Schaik RH; Lezhava A; Tzimas G; Kollia P; Macek M; Fortina P; Patrinos GP
Pharmacogenomics; 2012 Mar; 13(4):387-92. PubMed ID: 22379996
[TBL] [Abstract][Full Text] [Related]
14. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
15. Challenges and opportunities associated with rare-variant pharmacogenomics.
Zhou Y; Tremmel R; Schaeffeler E; Schwab M; Lauschke VM
Trends Pharmacol Sci; 2022 Oct; 43(10):852-865. PubMed ID: 36008164
[TBL] [Abstract][Full Text] [Related]
16. Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.
Scott SA; Owusu Obeng A; Botton MR; Yang Y; Scott ER; Ellis SB; Wallsten R; Kaszemacher T; Zhou X; Chen R; Nicoletti P; Naik H; Kenny EE; Vega A; Waite E; Diaz GA; Dudley J; Halperin JL; Edelmann L; Kasarskis A; Hulot JS; Peter I; Bottinger EP; Hirschhorn K; Sklar P; Cho JH; Desnick RJ; Schadt EE
Pharmacogenomics; 2017 Oct; 18(15):1381-1386. PubMed ID: 28982267
[TBL] [Abstract][Full Text] [Related]
17. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
Lauschke VM; Ingelman-Sundberg M
Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
[TBL] [Abstract][Full Text] [Related]
18. Technologies for Pharmacogenomics: A Review.
van der Lee M; Kriek M; Guchelaar HJ; Swen JJ
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33291630
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
